Phase2 study of Nab-Paclitaxel in patients with unresectable or advanced squamous cell lung cancer
- Conditions
- squamous cell lung cancer
- Registration Number
- JPRN-UMIN000014558
- Lead Sponsor
- Tottori University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 27
Not provided
1) Patient with need of procedure for pleural effusion 2) History of hypersensitivity against albumin preparation 3) Patient with need of drainage procedure for cardiac effusion 4) Patient with symptomatic brain metastasis 5) Patient with severe complications. 6) Patients with interstitial pneumonia or pulmonary fibrosis diagnosed by chest X-ray 7) Female Patient in or having a chance or planning of pregnancy or breast feeding, 8) Male patient in planning to impregnate 9) Patient with active multiple cancers. 10) Patients with history of drug hypersensitivity 11) Patinets with histoly of hypersensitivity against Txeane agents include paclitaxel and docetaxel 12) Case which was judged as impossible to perform by physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Disease Control Rate(DCR)
- Secondary Outcome Measures
Name Time Method Response Rate(RR), Overall Surivival(OS), Progress Free Survival(PFS), Safety